Your browser doesn't support javascript.
loading
Extracorporeal Membrane Oxygenation for Adult Patients With Neoplasms: Outcomes and Trend Over the Last 2 Decades.
Suzuki, Yota; Mobli, Keyan; Cass, Samuel H; Silva, Madeline M; DeAnda, Abe; Tyler, Douglas S; Radhakrishnan, Ravi S.
Afiliación
  • Suzuki Y; From the Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
  • Mobli K; From the Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
  • Cass SH; From the Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
  • Silva MM; University of Texas Medical Branch, Galveston, Texas.
  • DeAnda A; Division of Cardiothoracic Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
  • Tyler DS; From the Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
  • Radhakrishnan RS; Division of Cardiothoracic Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, Texas.
ASAIO J ; 69(2): 159-166, 2023 02 01.
Article en En | MEDLINE | ID: mdl-35417440
Extracorporeal membrane oxygenation (ECMO) is utilized in the management of severe respiratory and circulatory failure. Advanced malignancy is a relative contraindication, but the indication for ECMO in the oncologic population has not been clearly established because of the wide spectrum of malignant disease and prognoses. The Extracorporeal Life Support Organization database was queried for patients older than 18 years with an International Classification of Diseases code of neoplasm over the past 2 decades (2000-2019). The data were divided into 2 decades to analyze and compare the trends with background and outcomes. One thousand six-hundred ninety-seven patients met inclusion criteria from the latest decade which is over 15 times the previous decade (n = 110). Compared with the previous decade, ECMO was used more in patients with older age (56 vs . 50.5 years old; p < 0.001), cardiac and extracorporeal cardiopulmonary resuscitation (ECPR) support type ( p = 0.011), and lower oxygenation index (23.0 vs . 35.6; p < 0.001) in the latest decade. Although overall survival did not show significant improvement overall (38.9% vs . 33.6%; p = 0.312), survival in pulmonary ECMO has significantly improved in the latest decade (41.6% vs . 29.1%; p = 0.032). Compared with the previously reported data for all adult ECMO, our patients had a significantly lower survival with pulmonary (41.6% vs . 61.1%; p < 0.001) and cardiac (38.4% vs . 44.3%; p = 0.008) support while not with ECPR.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxigenación por Membrana Extracorpórea / Reanimación Cardiopulmonar / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: ASAIO J Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxigenación por Membrana Extracorpórea / Reanimación Cardiopulmonar / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: ASAIO J Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos